Kissei Pharmaceutical Co., Ltd.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public
- Established
- 1946-08-09
- Employees
- 1.7K
- Market Cap
- -
- Website
- http://www.kissei.co.jp
A Long-term Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-07-20
- Last Posted Date
- 2017-11-17
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Registration Number
- NCT02503163
A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-07-20
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Registration Number
- NCT02503189
Study of Absorption, Metabolism and Excretion Following a Single Oral Dose of [14C]KWA-0711 to Healthy Male Subjects
- First Posted Date
- 2015-05-05
- Last Posted Date
- 2016-04-18
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Registration Number
- NCT02434835
Phase II Study of KWA-0711 in Patients With Chronic Constipation (CC)
- First Posted Date
- 2015-01-22
- Last Posted Date
- 2017-05-22
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 37
- Registration Number
- NCT02343978
Phase II Dose-Finding Study of KWA-0711 in Patients With Chronic Constipation (CC)
- First Posted Date
- 2014-11-02
- Last Posted Date
- 2017-05-22
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 388
- Registration Number
- NCT02281630
Phase II Exploratory Clinical Study of KUX-1151
- First Posted Date
- 2014-07-15
- Last Posted Date
- 2015-10-19
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Registration Number
- NCT02190786
Post-marketing Clinical Trial of KAD-1229 in Patients With Type 2 Diabetes Mellitus
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-06-03
- Last Posted Date
- 2019-09-06
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 178
- Registration Number
- NCT02154347
A 24-week Open-label Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-10-25
- Last Posted Date
- 2016-04-18
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Registration Number
- NCT01970137
A Long-Term Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-10-25
- Last Posted Date
- 2016-04-18
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Registration Number
- NCT01970124
An Extension Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-10-25
- Last Posted Date
- 2016-04-18
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Registration Number
- NCT01970111
© Copyright 2024. All Rights Reserved by MedPath